REGENERON PHARMACEUTICALS (REGN) Stock Analyst Ratings
NASDAQ:REGN - Nasdaq - US75886F1075 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to REGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 952.52. This target is 69.14% above the current price.
REGN was analyzed by 34 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about REGN.
In the previous month the buy percentage consensus was at a similar level.
REGN was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-04-17 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-05 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-02-05 | Baird | Maintains | Neutral -> Neutral |
| 2025-01-28 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-16 | UBS | Downgrade | Buy -> Neutral |
| 2025-01-14 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-07 | Bernstein | Maintains | Outperform -> Outperform |
| 2024-12-17 | Canaccord Genuity | Initiate | Hold |
| 2024-12-10 | B of A Securities | Reiterate | Underperform |
| 2024-11-15 | Wolfe Research | Initiate | Outperform |
| 2024-11-14 | Citigroup | Initiate | Neutral |
| 2024-11-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-01 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-24 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-10-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-23 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-22 | RBC Capital | Reiterate | Outperform -> Outperform |